These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5154664)

  • 1. [Parameters for the clinical use of L-asparaginase].
    Mistretta AP; Astaldi G; Tassi GC; DeBarbieri A
    Ann Ist Super Sanita; 1971; 7(2):405-7. PubMed ID: 5154664
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of L-asparaginase. Introduction.
    Burchenal JH; Karnofsky DA
    Cancer; 1970 Feb; 25(2):241-3. PubMed ID: 4905151
    [No Abstract]   [Full Text] [Related]  

  • 3. [Distribution of exogenous and endogenous L-asparaginase in mice].
    Wierer U; Pütter J
    Arzneimittelforschung; 1972 Apr; 22(4):791-5. PubMed ID: 5068262
    [No Abstract]   [Full Text] [Related]  

  • 4. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME; Ertel I; Hammond GD
    Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [L-asparaginase in the treatment of leukemia].
    Astaldi G; Burgio GR; Severi F; Genova R; Curtini E; Bruschelli M; Astaldi A
    Przegl Lek; 1971; 27(3):286-9. PubMed ID: 5280473
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetic behavior of L-asparaginase in men and in animals.
    Pütter J
    Recent Results Cancer Res; 1970; 33():64-74. PubMed ID: 5526349
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood level course in humans following administration of 2 various kinds of L-asparaginase].
    Pütter J; Gehrmann G
    Klin Wochenschr; 1969 Dec; 47(24):1324-6. PubMed ID: 5382022
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antibody sandwich enzyme-linked immunoadsorbent assay for determination of recombinant E. coli L-asparaginase in rat plasma and its pharmacokinetics].
    Chen JH; Wu WT; Kazuyuki H
    Yao Xue Xue Bao; 2003 Aug; 38(8):613-6. PubMed ID: 14628454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attempts at treatment of acute leukemia with L-asparaginase].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
    Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
    [No Abstract]   [Full Text] [Related]  

  • 10. [High molecular weight L-asparaginase derivatives based on a water-soluble carboxymethyl cellulose: biological properties].
    Karsakevich AS; Kinstler OB; Dauvarte AZh; Vina IA
    Vopr Med Khim; 1988; 34(3):107-10. PubMed ID: 3420797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of L-asparaginase in the treatment of pancreatic carcinoma.
    Lessner HE; Valenstein S; Kaplan R; DeSimone P; Yunis A
    Cancer Treat Rep; 1980; 64(12):1359-61. PubMed ID: 7471124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization and immunogenicity of silk fibroin-L-asparaginase bioconjugates.
    Zhang YQ; Zhou WL; Shen WD; Chen YH; Zha XM; Shirai K; Kiguchi K
    J Biotechnol; 2005 Nov; 120(3):315-26. PubMed ID: 16102867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fluorometric assay for L-asparaginase activity and monitoring of L-asparaginase therapy.
    Ylikangas P; Mononen I
    Anal Biochem; 2000 Apr; 280(1):42-5. PubMed ID: 10805519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The L-asparaginase in the treatment of leukemias].
    Rass Int Clin Ter; 1971 Feb; 51(4):247-8. PubMed ID: 5280729
    [No Abstract]   [Full Text] [Related]  

  • 15. Age and asparaginase side-effects.
    Khan A
    Lancet; 1972 Jan; 1(7743):206-7. PubMed ID: 4109581
    [No Abstract]   [Full Text] [Related]  

  • 16. L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans.
    Riccardi R; Holcenberg JS; Glaubiger DL; Wood JH; Poplack DG
    Cancer Res; 1981 Nov; 41(11 Pt 1):4554-8. PubMed ID: 6895481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Absorption in vitro, by malignant cells, of serum proteins of rabbits and agoutis (l-asparaginase) conjugated with fluorescent substances].
    Wanick LR
    Rev Inst Antibiot (Recife); 1971 Jun; 11(1):39-42. PubMed ID: 5161610
    [No Abstract]   [Full Text] [Related]  

  • 18. Gel entrapment of enzyme. A strategy for enzyme correction.
    Nadler HL; Updike SJ
    Enzyme; 1974; 18(1):150-60. PubMed ID: 4604500
    [No Abstract]   [Full Text] [Related]  

  • 19. Factors influencing the therapeutic activity of L-asparaginase (NSC 109229) in leukemic (L5178Y) mice.
    Vadlamudi S; Padarathsingh M; Waravdekar VS; Goldin A
    Cancer Res; 1970 May; 30(5):1467-72. PubMed ID: 5426950
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in researches on anti-tumor agent L-asparaginase for treatment of leukemia].
    Zhou J; Jin H; Li Y; Jiang T
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2000 Sep; 17(3):343-5. PubMed ID: 11285852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.